Sooam Biotech is a Seoul dog-cloning operation founded in 2006 by Hwang Woo-suk after his famous scientific-fraud scandal, and it has since produced 1,000+ commercial dog clones. The dossier's point: the public scandal discredited the headlines while the underlying cloning capability was real — and was quietly scaled into a multi-million-dollar business.
Founded 2006 by Hwang Woo-suk post-Science-paper-fraud as the substrate-tier successor to his discredited Seoul National University position. 1,000+ commercial dog clones produced to date.
Optimized canine SCNT to industry-leading ~30% pregnancy rates via in-vivo progesterone-timed oocyte collection (dogs ovulate immature oocytes; in-vitro maturation has no high-efficiency protocol).
Engine framing: Substrate-vs-Announcement canonical 2005-2006 instance. Announcement layer (Hwang fraud → SCNT discredited) shielded substrate layer (Snuppy 2005 was real → Sooam scaled validated canine SCNT into a multi-million-dollar enterprise). Demonstrates that announcement-layer collapse does not invalidate substrate-layer mechanics.
ViaGen Pets is the Texas company that has cloned pets commercially since 2015 — 600+ dogs and 400+ cats at roughly $50,000 per dog — operating in ordinary veterinary jurisdiction entirely outside academic ethics rules. The dossier ties it to the same mortality-anxiety capital behind longevity ventures, noting the public still treats pet cloning as fringe novelty when it is an industrialized assembly line.
Successor to Genetic Savings & Clone (founded 1997, dissolved 2006); re-launched commercial pet cloning 2015 from inherited mechanics + customer base.
600+ cloned dogs + 400+ cloned cats by 2024. ~25% global pet-cloning market share. Per-dog cost ~$50,000. Operates entirely outside Western academic ethical moratoria — pure commercial-veterinary jurisdiction.
Engine framing: cap-table-adjacent to Longevity Industrial Complex operator-class capital — same mortality-anxiety conversion mechanism (immortality drives) applied to companion-animal layer. Public perception treats pet cloning as fringe novelty; market reality is industrialized elite-genetic-replication assembly line.
Sinogene is a Beijing pet-cloning company (launched 2017, 500+ clones) that maintains a breeding base of 1,000+ laboratory beagles as surrogate infrastructure — physical capacity Western academic labs could not legally keep. The dossier reads it as regulatory arbitrage: capital flows to where rules are loosest, so offshore commercial labs absorb the work Western regulation excluded.
Launched commercial cloning services 2017. 500+ pet clones produced. Maintains 1,000+ laboratory beagle breeding base for surrogate infrastructure — physical capacity Western academic research cannot legally maintain.
Per-canine clone cost €20,000-€60,000. Demand driven by Chinese pet-humanization trends + high-net-worth capital + low domestic regulatory friction.
Engine framing: regulatory-arbitrage substrate node. Apex (b) Institutional-Competition load-bearing — capital seeks path of least resistance; offshore commercial environments absorb the substrate that Western academic regulatory regimes excluded.
Trans Ova Genetics is Iowa's industrial livestock cloner: 2,000+ clone births, a 90% embryo-viability rate, and FDA clearance since January 2008 for meat and milk from cloned animals and their offspring. The dossier's observation: an entire cloning industry has operated for over 18 years with almost no public awareness.
Apex agricultural-livestock SCNT operator. 2,000+ livestock clone births globally. 90% embryo-viability success rate.
FDA cleared January 2008: final risk assessment concluded meat + milk from cloned cattle/pigs/goats + sexually-reproduced offspring safe for human consumption. Cleared for >18 years without significant announcement-layer salience.
Agricultural-biotech VC has driven ~30% cost reduction per cloning cycle via SCNT automation. Engine framing: Genesis Physical Substrate biological-tier — industrial bio-manufacturing pipeline operating without public-discourse salience since 2008.
The Mitalipov lab at Oregon Health & Science University is the main remaining US academic hub for human cloning-technique and embryo-editing research — it achieved human SCNT to the blastocyst stage in 2013. The dossier notes the recurring pattern: the science advances in the US while clinical application migrates offshore — the first birth from its mitochondrial-replacement technique happened in Mexico because a US funding rider forbids such trials.
Shoukhrat Mitalipov's laboratory is the primary continued US node for human SCNT + germline research. 2013: human SCNT to blastocyst stage (Cell). 2016: spindle-transfer mitochondrial replacement therapy — first live birth executed in Mexico under Dr John Zhang due to FDA appropriations rider prohibiting US germline clinical trials.
2025: Nature Communications + Fertility and Sterility papers advocating targeted CRISPR-Cas9 correction of inherited mutations in preimplantation embryos.
Engine framing: DNA-as-Transducer divergence substrate instance — enucleated-oocyte reprogramming provides the natural epigenetic-reset environment that biochemical-determinist paradigm cannot model. Continuous Western academic-tier push toward human germline editing; clinical execution migrates offshore.
He Jiankui is the Chinese scientist who created the first gene-edited babies in 2018, served a 3-year prison sentence, and by 2025 was announcing new gene-therapy trial plans from a lab in Hainan. The dossier reads his arc as evidence that professional excommunication does not stop the work: private funding and lab space remained available despite official condemnation.
**2018:** CRISPR-Cas9 edits to CCR5 gene in human embryos → birth of three genetically modified children (Lulu, Nana, Amy) for HIV resistance. International scandal; 3-year prison sentence in China for 'illegal medical practice.' Released 2022.
**Sep 2023:** appointed director of Institute of Genetic Medicine at Wuchang University of Technology — appointment LOST shortly after per negative-press response (NOT current). Lab is in HAINAN, not Beijing (Beijing-lab claim itself functions as announcement-layer theater).
**2025:** announced gene-therapy clinical trial plans for Duchenne muscular dystrophy (DMD), framed as affordable-genetic-therapy. Engine framing: Substrate-vs-Announcement disclosure-window-probe pattern — operator ambition supersedes institutional excommunication; private funding + lab space remain accessible despite Chinese academic-community condemnation. Apex (a) Coordinated-state-strategic-research + (b) Turchin SDT grey-zone both load-bearing — FDA Plausible Mechanism Framework 2026 absorbs substrate trajectory at regulatory layer.
This entry covers the Chinese Academy of Sciences labs in Shanghai that produced the first cloned macaques (2018) and a cloned rhesus monkey (2024), then launched a 25-year state-subsidized primate brain-mapping program. The dossier explicitly frames this not as a China-rising story but as substrate monopolization: one state institution now holds exclusive infrastructure for mass-producing genetically identical primates, because Western competitors are constrained out by ethics and regulation.
**Jan 2018:** Institute of Neuroscience Shanghai announces Zhong Zhong + Hua Hua, first SCNT-cloned macaques. Overcame primate-nuclear epigenetic-reprogramming resistance via fetal-fibroblast source cells + injected epigenetic modulators.
**2024:** Retro, first SCNT-cloned rhesus monkey, born via trophoblast-replacement method overcoming placental defects. **2025:** International Consortium for Primate Brain Mapping (ICPBM) launched — 25-year multiomic primate-brain atlas initiative, heavily state-subsidized.
Engine framing: NOT a 'successor power' narrative (Technate node-framing binding) — the pattern is substrate monopolization. CAS now possesses exclusive infrastructure to mass-produce genetically identical primate models for neurodegenerative disease + pharmaceutical pipelines. Western competition absent due to ethical / regulatory constraints. Apex (a) Coordinated-state-strategic-research load-bearing.
Colossal Biosciences is the 'de-extinction' startup valued at $10.2B whose famous 2025 dire-wolf announcement was, by its own chief scientist's admission, actually gray wolves with 20 gene edits — too little to resurrect a species that diverged ~5.7M years ago. The dossier flags the CIA's venture arm In-Q-Tel on the investor list, reading the strategic interest as the computational-biology software stack rather than the animals themselves.
Co-founded 2021 by Ben Lamm + Harvard geneticist George Church. Total funding $568.1M; Series C $200M Jan 2025 → $10.2B valuation. Cap table: TWG Global (Thomas Tull), USIT, Breyer Capital, Draper Associates, Animoca Brands, **In-Q-Tel (CIA venture arm)**.
**2025/2026 dire wolf announcement:** marketed as first successful de-extinction. **Substrate correction:** Colossal made 20 CRISPR edits across 14 loci on a MODERN GRAY WOLF genome — gray wolves with 20 edits, NOT de-extincted dire wolves. Beth Shapiro (Colossal chief scientist) explicit May 2025 admission: 'grey wolves with 20 edits.' Perri et al 2021 Nature: dire wolves diverged ~5.7M years ago — too phylogenetically distant for de-extinction via gray-wolf scaffold. IUCN SSC + MIT Tech Review 'eight worst flops of 2025' treat as overclaim.
Engine framing: Substrate Shift Biological→Silicon Enclosure substrate node. In-Q-Tel position indicates strategic state interest in the bioinformatics + computational-biology stack (Form Bio spinout) rather than the de-extinct animals themselves. Cap-table siblings: Altos Labs (Bezos), Retro Bio (Altman), Unity Bio (Thiel), Calico (Alphabet) — same operator-class capital pool as Longevity Industrial Complex. Apex (d) Undecidable load-bearing.
Clonaid is the human-cloning company founded by the Raëlian UFO religion, which in December 2002 announced 'Baby Eve,' allegedly the first human clone — with zero DNA verification, and courts and scientists dismissed it as a hoax. The dossier treats it as its cleanest case of spectacle covering substance: the absurd alien theater absorbed press and regulator attention while real cloning work proceeded elsewhere — recorded as an obfuscation mechanism, explicitly not as proof of a coordinated program.
**The object.** The Raëlian Movement (Claude Vorilhon/'Raël', 1973; aliens-created-us 'Elohim' theology) founded Clonaid (1997), directed by chemist Brigitte Boisselier (two PhDs, ex-Air Liquide). In Dec 2002 it announced 'Baby Eve' — allegedly the first human clone — and provided ZERO DNA verification. Courts and science dismissed it as a hoax; Boisselier testified the baby was 'in Israel,' and the case was dismissed for lack of jurisdiction.
**Why it matters structurally.** The FDA probed a REAL lab (a rented room in a former Nitro, WV high school) funded by ex-legislator Mark Hunt, who wanted to clone his deceased son. The absurd alien theology + the debunkable 'Eve' spectacle absorbed the regulatory and press attention while serious genomic work proceeded behind corporate walls. That is the announced layer (UFO cult, fake clone) decoupled from the substrate (real cloning capital) — your 'eugenics, not aliens' thesis in one documented case.
**Held honestly.** The 'Elohim' and the 'Eve' clone are [CLAIM], never [FACT] — no clone was ever verified. Recorded as a Substrate-vs-Announcement instance and an obfuscation mechanism, NOT as proof of a coordinated program.
This entry documents the American legal origin of the eugenics infrastructure: the Eugenics Record Office at Cold Spring Harbor wrote the 1914 model sterilization law that Germany's 1933 law copied, engineered the 1927 Buck v. Bell Supreme Court test case, and 65,000+ Americans were forcibly sterilized across 30 states. The dossier traces documented funding and personnel bridges from Rockefeller Foundation money to the German race-science institutes — while explicitly declining to promote a single-cabal reading of those bridges.
**The nerve-center.** The Eugenics Record Office (Cold Spring Harbor, 1910) under Charles Davenport and Harry Laughlin turned biological determinism into enforceable policy. Laughlin's 1914 Model Eugenical Sterilization Law was the legislative blueprint — and the direct template for the 1933 German sterilization law (Laughlin noted it read 'almost like the American model'; Heidelberg gave him an honorary MD in 1936 for 'racial cleansing').
**Buck v. Bell (1927).** The ERO engineered the test case — Estabrook testifying that Carrie Buck's infant 'showed backwardness' (the child later made the school honor roll). Holmes: 'three generations of imbeciles are enough.' Result: 65,000+ Americans forcibly sterilized across 30 states. [PRIMARY: 274 U.S. 200]
**The bridge.** Rockefeller Foundation capital funded the Kaiser Wilhelm Institute (Eugen Fischer, 1927), whose institute-lineage runs Fischer → Verschuer → Mengele's DFG-funded Auschwitz pipeline. These are documented funding/personnel bridges (recurrence), held at (b)+(c) — the engine does NOT promote a single-cabal reading.
A brief pointer card: pig-organ transplants, artificial-womb research, lab-made reproductive cells and human-animal chimeras extend the post-Dolly cloning story into what the dossier calls a body-as-resource economy. The card carries almost no further detail, and the question of what drives the pattern is held open.
Pig-organ xeno, ectogenesis, IVG and human-animal chimera extend the post-Dolly substrate into a body-as-resource economy; held, apex superposition intact.
Walk this on the live map →